Apimeds Pharmaceuticals US, Inc. APUS
1.60 USD -0.14 (-8.05%)
Regular-session close
1.45 -0.15 -9.38%
After hours · Nov 20, 5:51 PM ET
1.51 Day range 1.77
1.60 52-week range 30.00
- YTD
- -90.24%
- 1 year
- -93.33%
No chart data for this range yet.
- Market cap
- 2.96M
- EPS (ttm)
- -12.69
- YTD return
- -90.24%
- 1-year return
- -93.33%
- Volume
- 48.66K
- Avg volume
- 3.74M
- Open
- 1.77
- Previous close
- 1.74
- Day's range
- 1.51 – 1.77
- 52-week range
- 1.60 – 30.00
Fundamental scorecard
2 of 25 checks passed on APUS’s reported financials
2of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
APUS Revenue — quarterly 2.90M
APUS Net income — quarterly 33.65M
APUS EPS — quarterly 19.13
News
Apimeds Pharmaceuticals US Reports Third Quarter 2026 Results, Delivers First Operating Revenue from Technology Services
$NILA Token Now Trading on PICOL, Opening Access for Eligible Users in South Korea
12 Health Care Stocks Moving In Wednesday's Pre-Market Session Apimeds’ Subsidiary MindWave Innovations Enters Into Shareholders’ And JV Agreement With Skalup Capital To Establish Insurance And Technology Business In Bermuda Under Working Brand Monaco Insurance
Your note
Sign in to keep a note on APUS — it syncs with the Stock Master app.
